Retinal vessel occlusion can steal vision in minutes
Retinal vessel occlusion is an eye emergency because the retina depends on a small, highly vulnerable blood supply. One artery and one vein carry most of the circulation to this light-sensitive tissue, and a blockage in either vessel can disrupt vision quickly. When the main retinal artery closes, sight can vanish suddenly and permanently if blood flow is not restored fast enough. A blocked retinal vein follows a different course, but it can still damage the retina through hemorrhage, swelling, and pressure-related injury.
The condition often arrives without pain. That makes the sudden change in vision all the more alarming, because a person may otherwise feel well while a critical blood vessel in the eye has already shut down.
Arterial blockage threatens retinal tissue within hours
A retinal artery occlusion deprives the retina of oxygen-rich blood. The retinal cells begin to suffocate almost immediately, and depending on how complete the obstruction is, they can die within minutes or hours. Once that happens, the visual loss is often substantial and lasting. The urgency is not abstract; this is one of the clearest examples in medicine of tissue that cannot wait.
Two mechanisms explain most adult cases. In one, a thrombus forms directly inside the artery at a site where the vessel lining has already been damaged by chronic disease such as hypertension, diabetes, or atherosclerosis. In the other, an embolus — usually a tiny clot or plaque fragment — travels from the heart, aorta, or carotid artery and lodges in the retinal circulation. In that second scenario, the eye can become the warning system for disease elsewhere in the body, especially in the carotid arteries.
Less common causes include vasculitis, trauma, sickle cell disease, clotting disorders, oral contraceptives, and radiation injury. Older adults with cardiovascular disease, high blood pressure, or diabetes face the greatest risk. In almost all cases, only one eye is affected. Diabetic retinopathy follows a related vascular logic, although it involves much smaller arteries and a different disease pattern.
A sudden curtain over one eye can be the first clue. About 10% of patients with retinal artery occlusion have prior episodes of amaurosis fugax, a brief and transient drop in vision that may last 10 to 15 minutes before the major event follows.
Vein occlusion backs blood up and damages the retina differently
A retinal vein occlusion blocks blood from draining out of the eye. Once venous outflow is obstructed, pressure rises behind the blockage and small hemorrhages, swelling, and tissue injury follow. Vision loss can range from mild blurring to major impairment, depending on how much of the retina is involved.
The risk profile is broad but recognizable: older age, hypertension, diabetes, smoking, glaucoma, and hypercoagulable states. Those clot-prone conditions may be inherited or acquired through another illness, including systemic lupus or some cancers. Unlike arterial occlusion, venous blockage may develop more gradually over days or weeks, although the symptom is still usually painless.
This difference in tempo matters at the bedside. A patient with a vein occlusion may describe a slower dimming or blur, while an artery occlusion more often presents as abrupt and dramatic monocular vision loss. Both demand prompt ophthalmologic attention, but the arterial event is treated as a true emergency because retinal survival time is short.
Diagnosis depends on urgent eye examination and vascular clues
Diagnosis begins with symptom review and a careful medical history. Prior high blood pressure, heart disease, diabetes, glaucoma, eye trauma, and amaurosis fugax all help frame the possibility of vascular eye disease. A thorough eye examination follows, including visual acuity and peripheral vision testing, dilation of the pupils, and direct inspection of the retina.
An ophthalmoscope or slit lamp can reveal a whitening of the retina, hemorrhage, a visible embolus, or other signs of impaired blood flow. Fluorescein angiography may be used to study circulation within the eye more closely. In older adults, retinal artery occlusion can also be caused by temporal arteritis rather than a thrombus or embolus, so blood tests such as erythrocyte sedimentation rate and C-reactive protein are often ordered, with ultrasound or biopsy used when needed to confirm the diagnosis.
When emboli from elsewhere in the body seem likely, evaluation extends beyond the eye. Heart and carotid blood flow may need to be assessed, and cholesterol or clotting studies may be ordered, especially in younger people. The eye problem may be the visible endpoint of a broader vascular disorder.
Treatment is limited for arterial occlusion and more established for venous disease
For retinal artery occlusion, time is critical, but treatment options remain limited. None has been proven definitively effective, and some may even worsen the situation. Approaches include direct thrombolytic injection near the blocked artery, anterior chamber paracentesis to reduce pressure in the eye, medications that lower eye pressure such as eye drops, acetazolamide, or mannitol, ocular massage in hopes of shifting the blockage, and vasodilators such as nitroglycerin, isosorbide, or pentoxifylline.
When temporal arteritis is responsible, high-dose corticosteroids are used, sometimes with immunosuppressive treatment such as tocilizumab, and the steroid dose is tapered gradually over many months.
Retinal vein occlusion is handled differently. Many cases do not require urgent intervention, but they are monitored closely for macular edema and neovascularization, the abnormal growth of small retinal vessels. Anti-VEGF injections such as ranibizumab or aflibercept are standard therapy. Corticosteroids, either injected into the eye or delivered through an implant, can also help. If clotting elsewhere in the body is present at the same time, blood thinners may be recommended. In a small branch vein occlusion, laser photocoagulation can help seal damaged areas and improve vision.
Prevention and prognosis depend on vessel type and speed of care
Prevention centers on vascular health. Stopping smoking, controlling blood pressure, cholesterol, and blood sugar, and maintaining routine dilated eye exams for people with diabetes all reduce risk. Protective eyewear at work and during sports can help prevent traumatic arterial occlusion, and seat belts reduce the chance of facial or eye injury in a crash.
If the retina’s arterial circulation remains blocked beyond 24 hours, vision loss may become permanent. Prognosis is generally poor when the entire retinal artery is occluded, especially after symptoms have lasted more than a few hours. Branch occlusions fare better. The same pattern applies to vein disease: full-vein blockage carries a worse outlook than blockage of a small branch. Vision can sometimes be preserved, but the final result depends heavily on the extent of the occlusion and the speed with which care begins.